Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.
  • Page:
  • 1

Investor Evening - 28 February - Edinburgh - ANGLE, Avation, Cadence, First Sentinel, SkinBioTherapeutics & Sound Energy     

Bullshare - 25 Jan 2018 14:29

Come and join Shares and AJ Bell Media at their Edinburgh investor evening on Wednesday 28 February 2018.
 
Our evening event provides an opportunity for Board Directors, from dynamic companies that are listed on the London Stock Exchange, to make a presentation and talk about their company business plans for 2018 direct to existing & potential investors.
 
During the event and afterwards over drinks, investors will have the chance to get to know the companies better by talking one on one with the company directors.
 
All attendees will be entered into free prize draws for:
 
Sparkling afternoon tea for TWO in majestic surroundings of The Dome’s Georgian Tea Room in George Street, in the heart of the city of Edinburgh. http://www.thedomeedinburgh.com/
 
Evening Wine Tasting Gift Experience at the Lothian Wine School in Edinburgh. A gift voucher for TWO places on one of their weekly evening tastings in Edinburgh City Centre. http://www.lothianwineschool.com
 
 
Companies booked to attend include:
 
ANGLE (AGL)  - ANGLE plc is a specialist medtech company listed on the London Stock Exchange AIM market.  ANGLE's lead product is the Parsortix micro-fluidic cell separation device, which can capture very rare circulating tumour cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy cells. ANGLE secured CE Mark regulatory authorisation for the clinical market in December 2013 and FDA authorisation work is in progress.
 
The primary application is the capture of circulating tumour cells (CTCs) in patient blood for;  Early detection of cancer; Personalised cancer treatment; Monitoring of cancer patients during treatment; and  Post-treatment monitoring of cancer patients in remission.
 
 
Avation (AVAP) - Avation PLC is a commercial passenger aircraft leasing company that was incorporated in England and Wales in 2006 and whose shares are admitted to the standard segment of the UK listing authority's official list and are traded on the Main Market of the London Stock Exchange (LSE: AVAP).
 
Avation owns and manages a fleet of aircraft which it leases, through its subsidiaries, to airlines across the world. Our customers include Flybe, Virgin Australia, Thomas Cook, Condor, Air France, easyJet, Eva Air, Philippine Airlines, Air India, Vietjet Air, Fiji Airways and Mandarin Airlines. The company’s fleet includes Airbus A320 family aircraft as well as Fokker 100s and ATR 72s.
 
 
Cadence Minerals (KDNC) - Cadence is dedicated to smart investments for a greener world. The planet needs rechargeable batteries on a global scale – upcoming supersized passenger vehicles, lorries and buses – require lithium and other technology minerals to power their cells. Cadence is helping find these minerals in new places and extracting them in new ways, which will meet the demand of this burgeoning market. With over £35 million vested in key assets globally, Cadence is helping us reach tomorrow, today.
 
 
First Sentinel - First Sentinel is a consortium of companies focused on alternative investments, specializing in equity and debt deals with appealing IRRs, as well as traditional Corporate Finance and Legal Services.
 
This consortium enables us to support our clients end to end, whether it be the individual investor or corporate offering.
 
First Sentinel PLC (NEX: FSEN) is an alternative investment company that provides growth capital for public and private company investments. 
 
 
PrimaryBid - PrimaryBid the leading online equity funding platform, available on both web and mobile, that enables investors to gain access to placings, fundraisings and IPOs of AIM-listed companies. The platform is open to all investors and is supported by the broking community as a way of accessing, on behalf of their AIM clients seeking capital, the large and active private investor market, as well as institutions.  To date almost £37m has been sourced for issuers, via the platform.
 
 
Sound Energy (SOU) - Sound Energy plc is a growth focused and private investor centric Moroccan gas explorerlisted on AIM and benefit from: a low cost, multi Tcf potential onshore gas discovery; a strategic partnership with Schlumberger - one of the largest companies in our sector; two supportive cornerstone investors; a potentially transformational drill programme, and a strong retail shareholder base
 
We are pursuing an onshore gas strategy underpinned by strong gas market fundamentals, which is proving very robust to the current oil price environment and to an increasingly carbon-conscious world. Gas is, rightly, seen as a cleaner alternative to coal and oil.
 
We are focused on unlocking the Moroccan gas promise, which includes:
 
Proving further volumes with three bold exploration wells in Eastern Morocco (starting early 2018), each with multi Tcf potential
 
De-risking of it’s 31 Tcf exploration potential in Eastern Morocco and up to 9 Tcf in Sidi Moktar through shooting new seismic and aerial gradiometry
 
Development of it’s existing 0.6 Tcf gas discovery (with first gas targetted for end 2019 / early 2020)
 
 
SkinBioTherapeutics (SBTX) - SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.
 
The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair and reduce bacterial load.
 
SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept.
Who Should Attend?

The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.

Date:

Wednesday 28 February 2018

Venue:

Radisson Blu Hotel Edinburgh, 80 High Street, The Royal Mile, Edinburgh, EH11TH

Event Timings:
17.30 
Registration and coffee
18.00 
Presentations
• Ian Griffiths, FD - ANGLE
• Andrew Newland, Chief Executive - ANGLE
• Richard Wolanski, Finance Director - Avation (AVAP)
• Kiran Morzaria, Director & CEO - Cadence Minerals (KDNC)
• Brian Stockbridge, CEO - First Sentinel
• Dave Mutton, COO - PrimaryBid
• Cath O'Neill, CEO - SkinBioTherapeutics
• JJ Traynor, CFO - Sound Energy (SOU)
21.00 
Drinks reception and canapés
22.00 
Close
PrimaryBid
PrimaryBid 

PrimaryBid is a leading FinTech business enabling investors to gain access to fundraisings of companies listed on UK Stock Exchanges.  Our unique solution connects the large and active pool of private investors, with companies seeking to raise capital by issuing new shares.

Traditionally, fundraises for listed companies have only been accessible by Institutions and a small number of high net worth investors, PrimaryBid allows all investors to have access to these fundraises at the same time and the same price, delivering open access regardless of the size of their investment.  To date over £52m has been sourced via the platform.

ANGLE
ANGLE 

ANGLE plc is a specialist medtech company listed on the London Stock Exchange AIM market (AGL.L).

ANGLE's lead product is the Parsortix micro-fluidic cell separation device, which can capture very rare circulating tumour cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy cells. ANGLE secured CE Mark regulatory authorisation for the clinical market in December 2013 and FDA authorisation work is in progress.

The primary application is the capture of circulating tumour cells (CTCs) in patient blood for:

·         Early detection of cancer;

·         Personalised cancer treatment;

·         Monitoring of cancer patients during treatment; and

·         Post-treatment monitoring of cancer patients in remission.

Avation (AVAP)
Avation (AVAP) 

Avation PLC is a commercial passenger aircraft leasing company that was incorporated in England and Wales in 2006 and whose shares are admitted to the standard segment of the UK listing authority's official list and are traded on the Main Market of the London Stock Exchange (LSE: AVAP).

Avation owns and manages a fleet of aircraft which it leases, through its subsidiaries, to airlines across the world. Our customers include Flybe, Virgin Australia, Thomas Cook, Condor, Air France, easyJet, Eva Air, Philippine Airlines, Air India, Vietjet Air, Fiji Airways and Mandarin Airlines. The company’s fleet includes Airbus A320 family aircraft as well as Fokker 100s and ATR 72s.

Cadence Minerals (KDNC)
Cadence Minerals (KDNC) 

Cadence is dedicated to smart investments for a greener world. The planet needs rechargeable batteries on a global scale – upcoming supersized passenger vehicles, lorries and buses – require lithium and other technology minerals to power their cells. Cadence is helping find these minerals in new places and extracting them in new ways, which will meet the demand of this burgeoning market. With over £35 million vested in key assets globally, Cadence is helping us reach tomorrow, today.

First Sentinel
First Sentinel 

First Sentinel is a consortium of companies focused on alternative investments, specializing in equity and debt deals with appealing IRRs, as well as traditional Corporate Finance and Legal Services.

This consortium enables us to support our clients end to end, whether it be the individual investor or corporate offering.

First Sentinel PLC (NEX: FSEN) is an alternative investment company that provides growth capital for public and private company investments. (NEX: FSEN).

 

SkinBioTherapeutics
SkinBioTherapeutics 

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair and reduce bacterial load.

SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept.

Sound Energy (SOU)
Sound Energy (SOU) 
Sound Energy plc is a growth focused and private investor centric Moroccan gas explorerlisted on AIM and benefit from: a low cost, multi Tcf potential onshore gas discovery; a strategic partnership with Schlumberger - one of the largest companies in our sector; two supportive cornerstone investors; a potentially transformational drill programme, and a strong retail shareholder base
 
We are pursuing an onshore gas strategy underpinned by strong gas market fundamentals, which is proving very robust to the current oil price environment and to an increasingly carbon-conscious world. Gas is, rightly, seen as a cleaner alternative to coal and oil.
 
We are focused on unlocking the Moroccan gas promise, which includes:
 
Proving further volumes with three bold exploration wells in Eastern Morocco (starting early 2018), each with multi Tcf potential

 

De-risking of it’s 31 Tcf exploration potential in Eastern Morocco and up to 9 Tcf in Sidi Moktar through shooting new seismic and aerial gradiometry

 

Development of it’s existing 0.6 Tcf gas discovery (with first gas targetted for end 2019 / early 2020)
Sponsored by:
AJ Bell Youinvest
PrimaryBid
  • Page:
  • 1
Register now or login to post to this thread.